The major defining pathological hallmarks of Alzheimer?s disease (AD) are the accumulations of amyloid ? (A?) and hyperphosphorylated Tau, associated with neuroinflammation, mitochondrial dysfunction, cytoskeletal aberrations, and synaptic loss. Multiple studies have shown that A?-induced neurotoxic signals require Tau, since the loss of Tau abrogates many deleterious effects of A?. Despite the clear pathogenic link between A? and Tau, a large knowledge gap exists in how A? pathogenically impinges on Tau. Our recently published and preliminary studies indicate that the Slingshot-1 homolog (SSH1)-Cofilin activation pathway and RanBP9 play critical roles in linking A? and Tau pathogenesis as well as their downstream neurotoxic signaling. Therefore, our central hypothesis is that RanBP9 and the Slingshot-Cofilin activation pathway not only mediate A?- induced neurotoxicity but also simultaneously promotes A? and Tau pathogenesis. By utilizing molecular, biochemical, cell biological, electrophysiological, viral, and histochemical tools, we propose to 1) test the effects of SSH1 inhibition as a potential therapeutic strategy to simultaneously reduce both A? and Tau pathogenesis; 2) validate the role of SSH1 and novel SSH1 inhibitors in A? secretion and Tau phosphorylation in primary neurons, and 3) determine the role of SSH1 and Cofilin activation status on Tau/MT dynamics and A? production in primary neurons.

Public Health Relevance

The defining pathological hallmark of Alzheimer?s disease (AD) is the accumulation of A? and Tau in brain associated with synapse loss, alterations in energy metabolism, inflammation of brain cells, and cognitive decline. This application utilizes integrated approaches in an effort to understand the molecular links between the A? and Tau pathologies as well as their neurotoxic actions. These studies are expected to shed novel insights to validating new therapeutic targets for AD by studying those that impinge on both A? and Tau simultaneously.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Multi-Year Funded Research Project Grant (RF1)
Project #
1RF1AG053060-01A1
Application #
9263591
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Yang, Austin Jyan-Yu
Project Start
2017-03-15
Project End
2022-02-28
Budget Start
2017-03-15
Budget End
2022-02-28
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of South Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Woo, Jung A; Liu, Tian; Zhao, Xingyu et al. (2017) Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes. Hum Mol Genet 26:3973-3988
Liu, Tian; Wang, Fang; LePochat, Patrick et al. (2017) Cofilin-mediated Neuronal Apoptosis via p53 Translocation and PLD1 Regulation. Sci Rep 7:11532